The experience of a sore mouth and associated symptoms in patients with cancer receiving outpatient chemotherapy

Cancer Nursing

Volumn 32, Issue 4, 2009, Pages 259-270

  Brown, Carlton G ^a   McGuire, Deborah B ^b   Peterson, Douglas E ^c   Beck, Susan L ^d   Dudley, William N ^e   Mooney, Kathleen H ^d  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Associated symptoms; Chemotherapy; Oral mucositis

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; ANXIETY; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; FATIGUE; FEMALE; FLUID INTAKE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOUTH PAIN; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OUTPATIENT CARE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF NURSING CARE; TELEPHONE;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ANTINEOPLASTIC AGENTS; ATTITUDE TO HEALTH; COST OF ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NURSING METHODOLOGY RESEARCH; ONCOLOGIC NURSING; OUTPATIENTS; PAIN; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STOMATITIS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 67651125044     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181a38fc3     Document Type: Article

References (49)

1. Dodd MJ, Larson PJ, Dibble SL, et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum. 1996;23(6):921-927.
2. McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20(10):1493-1502.
3. Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. Cancer Nurs. 2002;25(6):461-469.
4. Borbasi S, Cameron K, Quested B, Olver I, To B, Evans D. More than a sore mouth: patients' experience of oral mucositis. Oncol Nurs Forum. 2002;29(7):1051-1057.
5. Armstrong TS. Symptoms experience: a concept analysis. Oncol Nurs Forum. 2003;30(4):601-606.
6. Brown C, Beck S, Peterson D, McGuire D, Dudley W, Mooney K. Patterns of sore mouth in outpatients with cancer receiving chemotherapy. Support Care Cancer. 2009;17(4):413-428.
7. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100(9 suppl):2026-2046.
8. Peterson DE, Jones JB, Petit RG. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 2007;109(2): 322-331.
9. American Cancer Society. Mouth sores painful for patients: new scoring system to aid in treating mouth sores. http://www.cancer.org/docroot/NWS/ content/NWS-1-1x-Mouth-Sores-Painful-for-Patients.asp. Published July 19, 1999. Accessed December 9, 2008.
10. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer. 1993;72(5):1612-1617. (Pubitemid 23249287)
11. National Cancer Institute. Oral complications of chemotherapy and head and neck radiation. http://www.cancer.gov/cancertopics/pdq/supportivecare/ oralcomplications/healthprofessional. Updated 2008. Accessed December 9, 2008.
12. Roemer J. An end to outpatient chemotherapy? Medicare takes aim at reimbursement. J Natl Cancer Inst. 1999;91(17):1444-1445.
13. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98(7):1531-1539. (Pubitemid 37151510)
14. Miaskowski C, Dodd M, Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr. 2004;(32): 17-21.
15. Rutledge DM, McGuire C. Evidence-based symptom management. In: Yarbro CH, Frogge MH, Goodman M, eds. Cancer Symptom Management. 3rd ed. Sudbury, MA: Jones & Bartlett; 2003:3-14.
16. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001; 28(3):465-470.
17. National Institutes of Health. Symptom management in cancer: pain, depression and fatigue. http://consensus.nih.gov/2002/2002CancerPain DepressionFatiguesos022html.htm. Updated 2002. Accessed December 9, 2008.
18. Kim H, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28(4):270-282. (Pubitemid 41098333)
19. Elting LS, Shih YT. The economic burden of supportive care of cancer patients. Support Care Cancer. 2004;12(4):219-226. (Pubitemid 38678556)
20. Kolbinson DA, Schubert MM, Flournoy N, Truelove EL. Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol. 1988;66(1):130-138. (Pubitemid 18177254)
21. McGuire DB, Yeager KA, Dudley WN, et al. Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study. Cancer Nurs. 1998;21(6):385-393.
22. Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol. 2004;31(3 suppl 8): 35-44.
23. Keefe DMK, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs. 2004;20(1):38-47.
24. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 suppl):1995-2025. (Pubitemid 38528741)
25. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):2201-2205. (Pubitemid 32372323)
26. Vokurka S, Bystrická E, Koza V, et al. Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer. 2006;14(9):974-976. (Pubitemid 44244063)
27. Zalcberg J, Kerr D, Seymour L, Palmer M. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Eur J Cancer. 1998;34(12):1871-1875. (Pubitemid 28535434)
28. Chiara S, Nobile NT, Sanguineti O, Cognein P, Rosso R. Oral mucositis in advanced colorectal cancer patients receiving continuous 5-fluorouracil (5-FU) infusions (c.i.)+oral leukovorin (L-LV). Support Care Cancer. 1996:238.
29. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer. 2000; 8(5):366-371. (Pubitemid 30650520)
30. Sonis S, Sonis A, Lieberman A. Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc. 1978;97(3):468-472.
31. Eilers J, Berger AM, Peterson MC. Development, testing, and applications of the Oral Assessment Guide. Oncol Nurs Forum. 1988;15:325.
32. Elting LS, Keefe DMK, Sonis ST. Treatment-Induced Gastrointestinal Toxicity in Patients With Cancer. American Society of Clinical Oncology. Alexandria, VA; 2004:536-541.
33. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant. 2001;27 Suppl 2:S3-S11.
34. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006;12(3):229-241. 10.1111/j.1601-0825.2006.01258.x.
35. American Cancer Society. Sore or irritated mouth or throat. http://www.cancer.org/docroot/MBC/content/MBC-6-2x-Sore-or-Irritated-Mouth-or- Throat.asp. Updated 2008. Accessed December 9, 2008.
36. National Institute of Dental and Craniofacial Research. Chemotherapy and your mouth. http://www.nidcr.nih.gov/OralHealth/Topics/ CancerTreatment/ ChemotherapyYourMouth.htm. Updated 2008. Accessed December 9, 2008.
37. Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J Chronic Dis. 1987;40(10):939-942.
38. Bellm LA, Cunningham G, Durnell L, et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest. 2002;20(5-6): 793-800. (Pubitemid 37210053)
39. Magee T, Lee SM, Giuliano KK, Munro B. Generating new knowledge from existing data: The use of large data sets for nursing research. Nurs Res. 2006;55(2 suppl):S50-S56. (Pubitemid 44620337)
40. Mooney KH, Beck SL, Friedman RH, Farzanfar R. Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract. 2002; 10(3):147-154. (Pubitemid 34438458)
41. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129-138.
42. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4): 277-284.
43. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11): 2919-2925. (Pubitemid 36605163)
44. Wood LJ, Nail LM, Gilster A, Winters KA, Elsea CR. Cancer chemotherapy-related symptoms: evidence to suggest a role for pro-inflammatory cytokines. Oncol Nurs Forum. 2006;33(3):535-542. (Pubitemid 44870222)
45. Peterman A, Cella D, Glandon G, Dobrez D, Yount S. Mucositis in head and neck cancer: economic and quality-of-life outcomes. J Natl Inst Cancer Monogr. 2001;(29):45-51.
46. Francis DJ, Fletcher JM, Stuebing KK, Davidson KC, Thompson NM. Analysis of change: modeling individual growth. J Consult Clin Psychol. 1991;59(1):27-37.
47. Brown CG, McGuire DB, Beck SL, Peterson DE, Mooney KH. Visual graphical analysis: a technique to investigate symptom trajectories over time. Nurs Res. 2007;56(3):195-201.
48. Peterson DE, Keefe DM, Hutchins RD, Schubert MM. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer. 2006;14(6):499-504.
49. Doorenbos AZ, Berger AM, Brohard-Holbert C, et al. 2008 ONS research priorities survey. Oncol Nurs Forum. 2008;35(6):E100-E107.